Clinical studies
CLINICAL studies
Understanding clinical studies
Clinical studies refer to the series of scientific studies conducted in humans that validate the research and development stages in the discovery of a new medicine.
It is an essential step that is subject to rigorous regulatory controls.
Servier clinical trials
We believe that in order to develop medicines that better meet patient needs, we need to involve them in the process as early as possible, right from the R&D stage, either directly or through patient organizations.
Integrating the patient into every stage of R&D leads to closer ties between basic and clinical research, giving rise to what is known as translational research.
In this way, patients play a fundamental role in the process of developing new treatments.
Understanding translational medicine
Translational medicine takes a multi-disciplinary approach involving researchers, clinicians and patients, and forms a major component in clinical research and development.
Harnessing digital technology to speed up the research process
At Servier, digital technology and data increase agility and efficiency to speed up the research process, the identification procedure and clinical trials. They are an essential component of our R&D and develop a more detailed understanding of patients.
SCORE is the digitalization program for our clinical trials. It encourages remote dialogue between patients and medical and scientific teams by enabling them to access data in real time. The goal? To facilitate decision-making.
Five principles of transparency
The Servier Group complies with the five principles of transparency set out by the European Federation of Pharmaceutical Industries and Associations (EFPIA) for clincial trials.
100%
Servier publishes 100% of results from clinical trials carried out in Europe on the European Union Clinical Trials Register (EUCTR) website.
Our clinical development centers
Servier boasts a network of 15 clinical development centers, which are organized into three hubs in the North and South America, Europe and Asia-Pacific. They conduct local clinical trials in the Group’s therapeutic areas. They are operated by teams of highly qualified Servier employees.
Real-world studies
At Servier, we conduct real-world studies in all our therapeutic areas.
The aim of these studies is to enhance medical knowledge, as well as patient and doctor experiences. This is “real-life data,” reflecting the actual day-to-day lives of patients and health care professionals: the delivery of health care, management, and the impact of disease and treatment on daily life. This data is complementary to the data collected by interventional clinical studies.
By providing robust, additional analyses on the experience people have of living with diseases and medical treatment, real-life studies expand therapeutic understanding.